Print this page Bookmark and Share
Flash FAX

      David Kinsaul announced that effective January 2, 2008 Lisa Coffey will
      replace Bonnie Sommerville as the vice president for corporate support. 
      Since arriving at Dayton Children’s in 1988 Lisa has served in several
      important leadership positions, including director of ambulatory services.
       Lisa will have responsibility for facilities, information resources,
      dietary and material services.  In addition, Mr. Kinsaul announced some
      organizational changes to the Dayton Children’s structure.  For more
      information contact Tom Murphy, MD, at 937-641-5871.
      Dayton Children’s has been asked to participate in a new vaccine trial. 
      The study is investigating the use of a meningococcal conjugate vaccine in
      healthy toddlers.  The study ideally should be performed in a community
      practice setting.  Assistance from Dayton Children's research group will
      be provided to help run the trial.  Compensation is provided both to the
      physician, clinical investigator and to study patients.  If your practice
      might be interested in participating in this trial or if you need
      additional information, please contact either Sherman Alter, MD, at
      937-641-3329 or Linda Uhl at 937-641-4467.

      The Joint Commission and the Centers for Medicaid and Medicare Services
      want to assure that you, as physicians, are aware that you have a right to
      file a complaint with either agency if you feel that there are concerns
      with the quality of care at Dayton Children’s.  It is important that you
      know that there will be no retaliation from the hospital if you file a
      formal complaint.  We do, however, encourage you to try to resolve issues
      through the appropriate channels within the organization first.  You can
      always contact any member of senior management if you have a concern.  The
      following are telephone/web address contact points:
      Centers for Medicare and Medicaid Services  The Joint Commission
      Ohio Department of Health    Oakbrook, Illinois
      Telephone:  1-800-342-0553    1-800-994-6610
            Website:  www.jointcommission.org

      As of November 5, 2007, testing for the thrombophilia mutations, Factor V
      Leiden (R506Q) Prothrombin G20210A and Methylenetetrahydrofolate reductase
      (MTHFR) C677T, will be done using the AutoGenomics INFINITI molecular
      diagnostic testing platform.  Additionally, a second MTHFR mutation,
      A1298C, will now be detected.  This platform includes a multiplex PCR to
      amplify all the thrombophilia mutations above in a single reaction followed
      by automated detection by microarray hybridization after directed primer
      extension (DPE).
      Please use the following Sunquest test codes to order these tests – THROM
      for the complete panel; 5FLE for Factor V Leiden; PRT for Prothrombin
      G20210A and MTHFRB for MTHFR C677T and A1298C.
      For this assay, we require 1-3mL (0.5mL minimum) whole blood in an EDTA
      (purple top) tube.  Specimens will be batched and the assay performed
      weekly.  Results will be reported within seven days of receipt of
      specimen.  If you have any questions, please contact the genetics
      department at 937-641-3262.


Pediatric Link

Finding the latest trusted child health and safety information doesn't have to be hard. Pediatric Link, Dayton Children's e-newsletter offers timely and up-to-date information for health care professionals from the experts you trust at Dayton Children's.

Sign up

The Right Experts

Just right for all kids


The Children's Medical Center of Dayton Dayton Children's
The Right Care for the Right Reasons

One Children's Plaza - Dayton, Ohio - 45404-1815